Skip to main content
Top
Published in: Journal of Clinical Immunology 6/2010

Open Access 01-11-2010

Impaired Functions of Peripheral Blood Monocyte Subpopulations in Aged Humans

Authors: Joseph Nyugen, Sudhanshu Agrawal, Sastry Gollapudi, Sudhir Gupta

Published in: Journal of Clinical Immunology | Issue 6/2010

Login to get access

Abstract

Aging is associated with increased susceptibility to microbial infections, and monocytes play an important role in microbial defense. In this study, we have identified and compared four subpopulations of monocytes (CD14++(high)CD16, CD14+(low)CD16, CD14++(high)CD16+, and CD14+(low)CD16+) in the peripheral blood of young and aged subjects with regard to their numbers, cytokine production, TLR expression, and phosphorylation of ERK1/2 in response to pam3Cys a TLR-1/2 ligand. Proportions and numbers of CD14++(high)CD16+ and CD14+(low)CD16+ monocytes were significantly increased, whereas proportions of CD14+(low)CD16 monocytes were decreased in aged subjects as compared to young subjects. In aged subjects, IL-6 production by all four subsets of monocytes was significantly decreased, whereas TNF-α production was decreased in monocyte subsets, except the CD14+(low)CD16 subset. A significantly reduced expression of TLR1 was observed in CD14++(high)CD16+ and CD14+(low)CD16+ monocyte subsets in aged subjects. Furthermore, following pam3Cys stimulation, ERK1/2 phosphorylation was significantly lower in CD14+(low)CD16+, CD14++(high)CD16+, and CD14+(low)CD16 subsets of monocytes from aged subjects. This is the first study of four subpopulations of monocytes in aging, which demonstrates that their functions are differentially impaired with regard to the production of cytokines, expression of TLR, and signaling via the ERK–MAPK pathway. Finally, changes in the number of monocyte subsets, and impairment of TLR1 expression, TNF-α production, and EK1/2 phosphorylation was more consistent in CD16+ monocyte subsets regardless of expression of CD14high or CD14+low, therefore highlighting the significance of further subdivision of monocytes into four subpopulations.
Literature
1.
go back to reference Linton P, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5:133–9.CrossRefPubMed Linton P, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5:133–9.CrossRefPubMed
2.
go back to reference Caruso C, Buffa S, Candore G, Colonna-Romano G, Dunn-Walters D, Kipling D, et al. Mechanisms of immunosenescence. Immun Ageing. 2009;22:6–10. Caruso C, Buffa S, Candore G, Colonna-Romano G, Dunn-Walters D, Kipling D, et al. Mechanisms of immunosenescence. Immun Ageing. 2009;22:6–10.
3.
go back to reference Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000;31:578–85.CrossRefPubMed Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000;31:578–85.CrossRefPubMed
4.
go back to reference Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Ann Rev Immunol. 2008;26:421–52.CrossRef Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Ann Rev Immunol. 2008;26:421–52.CrossRef
5.
go back to reference Ziegler-Heitbrock L. The CD14+CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584–92.CrossRefPubMed Ziegler-Heitbrock L. The CD14+CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584–92.CrossRefPubMed
6.
go back to reference Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 1989;74:2527–34.PubMed Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 1989;74:2527–34.PubMed
7.
go back to reference Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 2007;317:666–70.CrossRefPubMed Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 2007;317:666–70.CrossRefPubMed
8.
go back to reference Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71–82.CrossRefPubMed Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71–82.CrossRefPubMed
9.
go back to reference Grage-Griebenow E, Lorenzen D, Fetting R, Flad HD, Ernst M. Phenotypical and functional characterization of Fcγ receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol. 1993;23:3126–35.CrossRefPubMed Grage-Griebenow E, Lorenzen D, Fetting R, Flad HD, Ernst M. Phenotypical and functional characterization of Fcγ receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol. 1993;23:3126–35.CrossRefPubMed
10.
go back to reference Wang SV, Mak KL, Chen LY, Chou MP, Ho CK. Heterogeneity of human blood monocytes: two subpopulations with different size, phenotypes, and functions. Immunology. 1992;77:298–303.PubMed Wang SV, Mak KL, Chen LY, Chou MP, Ho CK. Heterogeneity of human blood monocytes: two subpopulations with different size, phenotypes, and functions. Immunology. 1992;77:298–303.PubMed
11.
go back to reference Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006;211:609–18.CrossRefPubMed Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006;211:609–18.CrossRefPubMed
12.
go back to reference Weber C, Belge KU, van Hundelshausen P, Draude G, Steppich B, Meck M, et al. Differential chemokine receptor expression and functions in human monocyte subpopulations. J Leukoc Biol. 2000;67:699–704.PubMed Weber C, Belge KU, van Hundelshausen P, Draude G, Steppich B, Meck M, et al. Differential chemokine receptor expression and functions in human monocyte subpopulations. J Leukoc Biol. 2000;67:699–704.PubMed
13.
go back to reference Belge KU, Dayyani F, Horelt A, Siedler M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002;168:3536–42.PubMed Belge KU, Dayyani F, Horelt A, Siedler M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002;168:3536–42.PubMed
14.
go back to reference Mizuno K, Toma T, Tsukiji H, Okamoto H, Yamazaki H, Ohta K, et al. Selective expression of CD16highCCR2− subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation. Clin Exp Immunol. 2005;142:461–70.PubMed Mizuno K, Toma T, Tsukiji H, Okamoto H, Yamazaki H, Ohta K, et al. Selective expression of CD16highCCR2− subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation. Clin Exp Immunol. 2005;142:461–70.PubMed
15.
go back to reference Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169:4697–701.PubMed Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169:4697–701.PubMed
16.
go back to reference Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann Rev Immunol. 2002;21:335–76.CrossRef Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann Rev Immunol. 2002;21:335–76.CrossRef
18.
go back to reference Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987–95.CrossRefPubMed Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987–95.CrossRefPubMed
19.
go back to reference Jenssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol. 2003;16:637–46.CrossRef Jenssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol. 2003;16:637–46.CrossRef
20.
go back to reference Kim W-K, Sun Y, Do H, Autssier P, Halpern EF, Piatak M Jr., et al. Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol. 2010;87:557–67.CrossRefPubMed Kim W-K, Sun Y, Do H, Autssier P, Halpern EF, Piatak M Jr., et al. Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol. 2010;87:557–67.CrossRefPubMed
21.
go back to reference Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and diseases. Immunol Allergy Clin North Am. 2003;23:15–39.CrossRefPubMed Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and diseases. Immunol Allergy Clin North Am. 2003;23:15–39.CrossRefPubMed
22.
go back to reference Krabbe KS, Pedersen BK, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687–99.CrossRefPubMed Krabbe KS, Pedersen BK, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687–99.CrossRefPubMed
23.
go back to reference Boehmer ED, Meehan MJ, Cutro BT, Kovacs EJ. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev. 2005;26:1305–13.CrossRef Boehmer ED, Meehan MJ, Cutro BT, Kovacs EJ. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev. 2005;26:1305–13.CrossRef
24.
go back to reference Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. L Leukoc Biol. 2004;75:342–9.CrossRef Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. L Leukoc Biol. 2004;75:342–9.CrossRef
25.
go back to reference Van Duin D, Subhasis M, Thomas V, Ginter S, Montogomery RR, Fikrig E, et al. Age-associated defect in human TLR-1/2 function. J Immunol. 2007;178:970–5.PubMed Van Duin D, Subhasis M, Thomas V, Ginter S, Montogomery RR, Fikrig E, et al. Age-associated defect in human TLR-1/2 function. J Immunol. 2007;178:970–5.PubMed
26.
go back to reference Agarwal A, Agrawal S, Cao JN, Su H, Osann K, GUPTA S. Abberant innate functions of dendritic cells in aged humans: a role of PI3-K signaling pathway. J Immunol. 2007;178:6912–22. Agarwal A, Agrawal S, Cao JN, Su H, Osann K, GUPTA S. Abberant innate functions of dendritic cells in aged humans: a role of PI3-K signaling pathway. J Immunol. 2007;178:6912–22.
27.
go back to reference Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, et al. Different toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos. J Immunol. 2003;171:4984–9.PubMed Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, et al. Different toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos. J Immunol. 2003;171:4984–9.PubMed
28.
go back to reference Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter K, et al. Yeast zymosan, a stimulus for TLR-2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest. 2006;116:916–28.CrossRefPubMed Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter K, et al. Yeast zymosan, a stimulus for TLR-2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest. 2006;116:916–28.CrossRefPubMed
29.
go back to reference Kopp A, Buechlet C, Bala M, Neumeier M, Scholmerich J, Schaffler A. Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of xetracellular signal-regulated kinase and c-Jin N-terminal kinase but not interferon regulatory factor-3. Endocrinology. 2010;15:1097–108.CrossRef Kopp A, Buechlet C, Bala M, Neumeier M, Scholmerich J, Schaffler A. Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of xetracellular signal-regulated kinase and c-Jin N-terminal kinase but not interferon regulatory factor-3. Endocrinology. 2010;15:1097–108.CrossRef
30.
go back to reference Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR-1 and TLR-2 deficient mice. Nat Med. 2002;8:878–84.PubMed Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR-1 and TLR-2 deficient mice. Nat Med. 2002;8:878–84.PubMed
Metadata
Title
Impaired Functions of Peripheral Blood Monocyte Subpopulations in Aged Humans
Authors
Joseph Nyugen
Sudhanshu Agrawal
Sastry Gollapudi
Sudhir Gupta
Publication date
01-11-2010
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 6/2010
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9448-8

Other articles of this Issue 6/2010

Journal of Clinical Immunology 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.